NUTRITIONAL AND DIGESTIVE EFFECTS OF GASTRECTOMY FOR GASTRIC CANCER by C. Colavelli et al.
Wichtig Editore - © 2010 SINPE-GASAPE - ISSN 1828-6232 
Nutritional Therapy & Metabolism (2010; :3) 129-13628
129
INTRODUCTION 
Gastrectomy (G), subtotal or total, leads to a decrease of 
main gastric functions (1), but we only occasionally observe 
severe nutritional complications. In fact, G creates eating 
problems in nearly 30% of patients, but serious symptoms 
are present in only 1%-5% (2). The main complications of 
G are related to an abnormal passage of the bolus into the 
jejunum. In normal conditions, only food particles of less 
than 1 mm pass through the pylorus into the duodenum, 
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ABSTRACT
Background: Gastrectomy often leads to malnutrition.
Objective: The aim of this study was to analyze nutritional and digestive effects of gastrectomy for 
cancer. 
Patients and methods: Gastrectomized patients were studied by nutritional assessment including a 
weekly nutritional diary exploring digestive symptoms.
Results: Thirty-two patients were analyzed after a mean follow-up of 41.8 months. The mean 
percentage of weight loss was 12.9% ± 13.5%. After total gastrectomy, mean weight loss was 22% ± 
1.2%, against 7.4% ±11.9% for subtotal gastrectomy (p = 0.002). Moreover, advancing age was related 
to weight loss (p = 0.02), with a peak around 70 years. The most frequent postprandial symptoms were 
abdominal swelling (62%) and early satiety (59%). Finally, findings of the present study imply that over 
a long follow-up, there are no specific intolerances related to gastrectomy. 
Conclusions: Patients who have undergone a total gastrectomy and elderly gastrectomized patients 
are at risk of malnutrition and need postoperative nutritional support. 
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but after G, bigger and less digested particles reach the 
jejunum, and the enzymes at this level cannot hydrolyze 
these elements; this can cause malabsorption, reduction 
of caloric intake, and finally weight loss (3).
The main symptoms referred by gastrectomized patients 
are loss of appetite, early postprandial satiety, reflux, 
diarrhea, dyspepsia, nausea and/or vomiting, and 
alteration of taste. Generally, major and subcontinuous 
symptoms are present after total gastrectomy (TG), while 
minor or episodic symptoms are present after subtotal 
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- Late dumping syndrome appears 2 to 4 hours after a 
meal and is characterized by hypoglycemia caused by 
hyperinsulinemia; the symptoms can be perspiration, 
hunger, nausea, anxiety, cephalea, shaking, palpitation, 
and/or sweating.
(vi)  Roux-en-Y stasis syndrome (9) (only for SG with Roux-
en-Y reconstruction): characterized by delayed gastric 
emptying and vomiting. The causes of this syndrome can 
be functional, due to a long gastric remnant, or anatomical 
such as stenosis of a gastrojejunal anastomosis or jejunal 
loop obstruction due to adherences or kinking. 
The gastrointestinal symptoms and impairment of digestive 
and absorption process can lead to a reduction of food 
intake. If these alimentary restrictions remain for a long 
time, very serious malnutrition can occur.
All patients suffer weight loss, ranging from 10% to 15% 
during the postoperative period (3-5 weeks) (1, 10, 11), due 
to fasting related to ileus and surgical stress during the 
hospital stay in addition to eating problems related to G. 
After hospital discharge, the principal cause of weight loss 
is reduced caloric intake due to lack of appetite, presence 
of gastrointestinal symptoms related to food ingestion (12), 
changes in sense of hunger, lack of personal initiative, and 
sometimes the abandoning of nutritional advice. Loss of 
appetite and alteration in sense of hunger could be caused 
by the drop in plasma ghrelin levels after G, overall TG (13). 
This hormone is principally produced by endocrine cells of 
the stomach, and its function consists in inducing growth 
hormone secretion and stimulating appetite (8). Therefore, 
many studies demonstrate that of weight loss is mainly 
due to changes in fat mass (10, 11).
The purpose of this study is to analyze changes of nutritional 
status and digestive functions in patients affected by 
gastric cancer, determined by the following possible 
causes: presence and growth of cancer, surgery (G), 
adjuvant chemotherapy, and the postoperative adaptation 
of the digestive process.
PATIENTS AND METHODS 
The study was performed at IRCCS Istituto Clinico 
Humanitas of Rozzano (Milan) from September 2008 
to March 2009. The patients enrolled in the study had 
undergone G for localized gastric cancer and were free of 
disease. They were independent, collaborative adults who 
were adequately informed by the main investigator (L.C.) 
gastrectomy (SG). Depending on the prevalent causes 
leading to postgastrectomy symptoms, we can describe 
the following syndromes (2-7): 
(i) Small stomach syndrome (only for SG): due to the 
smaller capacity of the gastric stump to contain the bolus. 
This syndrome is very frequent and is usually transitory. 
The principal symptoms are early postprandial satiety, 
nausea, vomiting, and postprandial abdominal pain even 
after small quantities of food.
(ii) Afferent loop syndrome (only for SG with Billroth II 
reconstruction) (7): due to a delayed or inefficient emptying 
of the biliopancreatic juice collected in the afferent loop 
of the gastric stump. This is characterized by nausea, 
postprandial fullness, and abdominal pain which results 
generally in bilious vomiting. 
(iii) Gastric (for SG) or esophageal reflux (for TG) and bilious 
vomiting syndrome: caused by the reflux of alkaline liquid 
(bile and pancreatic juice) in the gastric stump (for SG) or 
in the esophagus (for TG), with gastritis or esophagitis, 
bilious vomiting, and dysphagia. This syndrome is due to an 
incorrect position of the anastomosis, with the afferent loop 
(containing bile and pancreatic juice) being too close to the 
gastric stump or to the esophagus, and is often observed 
in patients undergoing a Billroth II reconstruction after SG if 
a Braun jejunojejunal anastomosis is not performed.
(iv) Diarrhea/malabsorption (overall for TG) (8): caused by 
the rapid emptying of the stomach content into the small 
bowel, associated with a recruitment of liquids in the lumen 
because of the increased osmolarity. Present in about 20% 
of patients after a TG. The accelerated passage of the bolus 
in the jejunum can reduce digestive capacity, resulting in 
malabsorption and steatorrhea. The rapidity of the orocecal 
transit, bacterial overgrowth in the small bowel due to decrease 
of gastric acid secretion, and pancreatic insufficiency are 
the principal mechanisms determining steatorrhea. Diarrhea 
usually appears about 2 hours after a meal.
(v) Dumping syndrome (8): related to an accelerated 
passage of bolus or sugar in the jejunum. Its frequency 
varies from 5% in SG patients to more than 40% after TG; 
symptoms generally disappear in time, and less than 5% 
of cases lead to chronic disorders. There are 2 types of 
dumping syndrome: 
- Early dumping syndrome appears 15 to 30 minutes 
after a meal and is characterized by fullness, abdominal 
cramps, nausea, diarrhea, and in some cases vasomotor 
symptoms, such as tachycardia, postural hypotension, 
sweating, asthenia, redness, and syncope.
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basis of food consumed by each patient and reported in 
the nutritional diary. Finally, the caloric intake was compared 
with recommended daily allowances of the Italian Ministry of 
Health.
The relationship between the intake of pastry products, 
the percentage of simple carbohydrates, and the presence 
of symptoms correlated to late dumping syndrome was 
also investigated. The parameters considered for this 
analysis were (i) a percentage of simple carbohydrates 
more than 15% of the total caloric intake, considering that 
the normal daily intake should be between 10% and 15% 
(16); (ii) a consumption of pastry products ≥ 7 times/week, 
which corresponds to at least once a day; and (iii) the 
contemporary presence of at least 3 symptoms related to 
the late dumping syndrome (perspiration, hunger, nausea, 
anxiety, headache, shaking, palpitation, or sweating). 
Those foods which always lead to the appearance of 
gastrointestinal symptoms were considered as not 
tolerated. In particular, intake of milk and dairy products, 
reported in the literature as common cause of intolerance in 
gastrectomized patients, (8) and presence of postprandial 
symptoms, considering consumption frequency ≥ 7 times 
a week and the association with at least 2 of the following 
disturbances: epigastric pain, early satiety, nausea, 
vomiting, abdominal swelling, diarrhea, and saliva overflow 
for 4 or more days a week, were analyzed. These arbitrary 
parameters were used to exclude any casual association. 
Statistical analysis
All of the collected data were transferred into a database 
(Microsoft Access) and analyzed in collaboration with the 
biostatistics unit of the IRCCS Istituto Clinico Humanitas 
of Rozzano (Milan). Data are presented as number and 
percentage, or mean and standard deviation, or median 
and range, where appropriate. Graphics used are box-and-
whisker plots, in which the central horizontal line in each 
box represents the median, the top and bottom borders of 
the boxes show the 75th and 25th percentiles, respectively, 
and the whiskers show the 5th and 95th percentiles. 
Eventual differences between the variables were explored 
through Student’s t-test or the chi-square test with Fisher’s 
correction when appropriate, using a p value equal to 0.05 
as the significance limit. The association between age and 
the percentage of weight loss was explored through a 
linear regression. All of the analyses were performed using 
the Stata 10 program (http://www.stata.com/).
about the purpose of this study and were reassured that 
the information gathered would remain totally anonymous. 
Informed consent was obtained from all patients enrolled 
in the study.
inclusion criteria
Patients who had undergone SG or TG at least 4 months 
previously, and whose digestive system had been 
reconstructed by the Roux-en-Y technique were eligible 
for inclusion (14, 15). 
exclusion criteria
Patients with cancer disease still present or undergoing 
chemotherapy, and those who had collateral pathologies 
potentially influencing their nutritional status or digestive 
functions were excluded.
 
We collected anamnesis and nutritional assessment of 
each patient. First, for each patient, a chart was filled in, 
containing: 
- personal data (date of birth, social and family 
characteristics, nutritional habits); 
-  clinical anamnesis (histological diagnosis, tumor location, 
TNM staging, grading, follow-up, presence of associated 
pathologies); 
- surgery, date and type of operation (SG or TG); 
- chemotherapy, date and duration (neoadjuvant or 
adjuvant); 
- nutritional anthropometric parameters: height, usual weight 
(prepathological conditions), weight at hospital admission 
before surgery, weight at hospital discharge, minimum 
weight reached, actual weight, and the percentage of 
weight loss between usual and actual weight, and between 
the usual and minimum weight reached;
- previous food intolerance; 
- biochemical nutritional parameters (serum albumin, 
transferrin, lymphocyte count, and cholinesterase). 
Second, each patient was informed of how to fill in 
a nutritional diary for a week, reporting food intake, 
number of meals and snacks, digestive symptoms 
related to alimentation, nontolerated foods, and personal 
eating habits. The nutritional diary was completed for 
7 consecutive days to explore eating habits during both 
working and rest days. The daily caloric intake and intake 
of total and simple carbohydrates were calculated on the 
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RESULTS 
Thirty-two out of 36 patients completed the study 
answering all of the questions and filling in correctly all 
of the questionnaires. Valuations were carried out after a 
mean follow-up of 41.8 ± 30.8 months since G. Clinical 
characteristics of the series are reported in Table I. Twenty 
SG and 12 TG were carried out, associated with 28 
lymphadenectomies of the first and second level, and 4 
lymphadenectomies of the first level. Of the 32 patients, 
2 underwent neoadjuvant (preoperative) and 12 adjuvant 
(postoperative) chemotherapy. Table II shows the nutritional 
characteristics of the series. 
Weight changes are reported in Figure 1. We observed 
a mild decrease of weight before surgery (from usual to 
hospital admission before surgery) from a mean 70.5 ± 
14.6 kg to 68.7 ±14.6 kg, and a main weight loss during 
hospitalization with a mean 60.1 ± 12.9 kg (p < 0.001) on 
discharge after a median hospital stay of 11.5 days (range 
8-57). Unexpectedly, we did not find any statistically 
significant correlation between weight loss during 
hospitalization and length of hospital stay. For 14 patients 
(44%) minimum weight reached coincided with their weight 
on hospital discharge, whereas for the other 18 (56%) this 
was obtained a median of 2.5 months after surgery (range 
0-96). Valuation of actual weight showed a mean increase 
of 1.1 ± 7.3 kg with respect to hospital discharge weight, 
but only 5 patients (16%) recovered to their usual weight, 
Fig. 1 - Weight changes (in Kilograms). The central horizontal line 
in each box represents the median, the top and bottom borders of 
the boxes show the 75th and 25th percentiles, respectively, and the 
whiskers show the 5th and 95th percentiles.
taBle i - PATIENTS’ CLINICAL CHARACTERISTICS
Number of patients 32
Sex, male/female 18/14
Mean age (± SD)  66 (± 10)
Histologic type, no. of patients 
  Intestinal adenocarcinoma 13
  Undifferentiated diffuse adenocarcinoma 6
  Signet ring cell adenocarcinoma 5
  Mixed adenocarcinoma 8
Site of cancer, no. of patients 
  Cardias 3
  Fundus 1
  Body 4
  Greater curvature 2
  Lesser curvature 6
  Angulus 7
  Antrum 8
  Pylorus 1
Grading, no. of patients  
  G1 1
  G2 5
  G3 24
  GX 2
Stage T, no. of patients 
  T0 1
  T1 10
  T2a 5
  T2b 11
  T3 5
Stage N, no. of patients 
  N0 15
  N1 12
  N2 5
taBle ii - PATIENTS’ NUTRITIONAL CHARACTERISTICS
 no. of patients  Mean ± SD
Albumin, g/dL 22 4.2 ± 0.72
Transferrin, mg/dL 13 266 ± 86.2
Lymphocyte count, no./mm3 32 1.826 ± 538.4
Cholinesterase, kUI/L 9 21.3 ± 26.4
 
BMi                 no. of patients    Months  
                  since surgery
 
Underweight (BMI < 18) 4 31.3 ± 16.6
Normal weight (BMI 18-25) 24 39.8 ± 27.4
Overweight (BMI > 25) 4 64.3 ± 54
BMI = body mass index.
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the 12 patients who underwent adjuvant chemotherapy 
versus the 20 who did not was not statistically different 
considering the difference between mean usual and actual 
weight: 14% ± 11.9% and 11% ± 16.4%, respectively. 
Moreover, considering the minimum weight reached, we 
observed a mean weight loss of 20% ± 12% in patients 
who underwent adjuvant chemotherapy and 19% ± 8% 
in the others. However, 6 out of 12 patients reached the 
minimum weight loss during adjuvant chemotherapy; 4 of 
them had undergone SG and 2 TG. 
All of the patients reported 3 meals per day both before 
and after G and a median of 2 snacks (range 0-6) with an 
increase in number of snacks previously not included in 
daily habits. However, 17 of the 32 patients did not satisfy 
their estimated caloric requirement. We have also analyzed 
postprandial symptoms and their weekly frequency (Tab. 
III). The most frequent problems were abdominal swelling 
(20 patients), early satiety (19 patients), and sleepiness (14 
patients). The most sporadic symptoms were vomiting (2 
patients) and saliva overflow (2 patients), which usually 
appeared only after a heavy meal. 
Seventeen patients (53%) reported a wide variety of food 
intolerances, and in 9 of these more than 1 food caused 
disturbances (Tab. IV). There was no association between 
the length of time elapsed after surgery and the presence 
of food intolerance.
A further investigation was also made into the relationship 
between diet and late dumping syndrome, considering 
the percentage of simple carbohydrates more than 15% 
of the total caloric intake, an intake of pastry products ≥ 
7 times/week, and the contemporary presence of at least 
and all of these 5 patients had undergone SG. Comparing 
the usual with the actual weight, we observed that the 
mean percentage of weight loss was 12.9% ± 13.5%. 
We have considered possible factors influencing weight 
loss: type of G (TG vs. SG), age, and adjuvant chemotherapy. 
Patients who underwent TG presented a mean weight loss 
of 22% ± 1.2% against 7.4% ± 11.9% for SG (p = 0.002). 
Moreover, in patients younger than 70 years, with the rise 
in age there was a rise in weight loss (p = 0.02) (Fig. 2); our 
data had no statistical significance after this cutoff value. 
To estimate how adjuvant chemotherapy could influence 
weight loss chronically or acutely, we correlated the usual 
weight with the actual and minimum weight reached, both 
in patients who had undergone adjuvant chemotherapy 
and those who had not. The difference of weight loss in 
Fig. 2 - Weight loss and years of age. 
taBle iii - POSTPRANDIAL SYMPTOMS AND THEIR WEEKLY FREQUENCY
Symptoms no. of patients affected    Weekly frequency
     (days/week)
  1          2          3         4         5         6           7
Epigastric pain 6 1 1 1 2 0 0 1
Early satiety  19 4 4 3 1 0 0 7
Nausea  6 4 2 0 0 0 0 0
Vomiting  2 2 0 0 0 0 0 0
Abdominal swelling  20 4 4 2 5 1 1 3
Diarrhea 6 3 3 0 0 0 0 0
Saliva overflow  2 1 0 0 0 0 1 0
Sleepiness  14 4 1 0 3 3 1 2
Weakness  7 1 4 0 1 0 1 0
Taste alteration  5 2 2 0 0 0 0 1
Anorexia  4 0 0 0 4 0 0 0
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and still reported in many medical books. The explanation 
is due to the greater attention given, both by the population 
and general practitioners, to initial dyspeptic symptoms 
and to the increased availability of endoscopy.
Two of the more important factors leading to weight loss 
are surgery and hospitalization. This is due to surgical 
stress, postsurgical fasting, and hospital food. In fact, the 
main weight loss occurs during hospital stay and nearly 
50% (44%) of patients reach their minimum weight during 
hospitalization, despite this period being only a median 
11.5 days (range 8-57). Data in the literature demonstrate 
a loss of body protein mass during the early postoperative 
period (10) and loss of fat mass due to fat malabsorption, 
later in the follow-up (1, 10). This conclusion would suggest 
monitoring patient nutrition during hospitalization, avoiding 
useless fasting, and giving more attention to dietary 
surveys and indications for nutritional support, because of 
the high risk of malnutrition. This statement is even more 
important because more than 50% (56%) of patients show 
a further weight loss after hospital discharge. Furthermore, 
we have identified 3 groups of patients who have a higher 
risk of malnutrition: those who have undergone TG; elderly 
people, with a peak around 70 years of age; and some of 
those who must undergo adjuvant chemotherapy. This 
leads us to suggest that these patients need postoperative 
nutritional support. In particular, weight loss is always 
associated with TG, whereas after SG there is a group 
of patients with weight loss and another without, despite 
there being no differences in surgical technique. This claim 
is proven by a greater weight loss with a very small SD after 
GT and a smaller weight loss but with a very large SD after 
SG (mean weight loss 22% ± 1.2% and 7.4% ± 11.9%, for 
GT and SG, respectively). Therefore a more attentive check 
of digestive problems also in SG patients is suggested in 
the attempt to find the risk factors related to malnutrition 
in this group too. No patient returns to usual weight after 
TG, so it is important not to consider this parameter as a 
reference during nutritional surveys or treatments, and to 
inform the patient and the practitioner regarding this new 
status.
Regarding the nutritional follow-up, although the majority 
of patients were not able to fully restore their usual weight 
(Fig. 1), they reach a normal body mass index with their 
visceral proteins within the normal range (Tab. II). Lack of 
return to usual weight could be explained by a low caloric 
intake; in fact, 17 of the 32 patients did not satisfy their 
estimated caloric requirement. Moreover, the calculation 
3 symptoms related to the late dumping syndrome. Our 
results showed that only 3 patients presented all of the 
above characteristics. 
We analyzed the consumption of milk and dairy products 
and the presence of at least 2 of the following postprandial 
symptoms: epigastric pain, early satiety, nausea, vomiting, 
abdominal swelling, diarrhea, and saliva overflow. Six 
patients presented at least 2 symptoms for 4 or more days/
week, but only 2 of these had a milk consumption level of 
≥ 7 times/week.
Finally, we evaluated the relationship between drinking 
liquids during meals and the presence of 2 or more 
symptoms (epigastric pain, early satiety, nausea, vomiting, 
abdominal swelling, diarrhea, saliva overflow, etc) at least 
4 times a week. Even in this case, there was no significant 
association; in fact, in the 28 patients drinking liquids 
during meals, only 5 reported disturbances. 
DISCUSSION 
The data obtained from this study include the nutritional 
status, digestive effects, and eating habits in the 
intermediate and long-term follow-up period after G. 
Variations in the nutritional status will be discussed first 
and then the alimentary analysis. Regarding the weight 
variations, we have demonstrated that the presence of 
gastric cancer (difference between usual weight and weight 
at hospital admission before surgery) nowadays does not 
cause malnutrition, as opposed to that observed in the past 
taBle iV - NONTOLERATED FOODS
nontolerated foods no. of patients     
Fried food  4
Pastry products 8
Oranges/juice  3
Chocolate 4
Milk/dairy product 5
Meat  1
Pork products 2
Wine/alcoholic drinks 3
Spicy food  1
Vegetables 2
Fresh fruit 2
Pulses 2
Tomatoes  3
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CONCLUSION
The present study has demonstrated that G with a Roux-
en-Y reconstruction has an important impact on nutritional 
status, and it has identified 3 categories of patients who are 
more at risk of malnutrition and who need postoperative 
nutritional support: those who have undergone TG; elderly 
people, with a peak around 70 years of age; and in part 
those who must undergo adjuvant chemotherapy. Our study 
has also demonstrated that patients return to a normal 
nutritional status in the follow-up period, although this is 
different from their usual status, without restoring their 
usual weight. Furthermore, they tend to go back to their 
presurgery eating habits, slowly abandoning the nutritional 
advice (17) received after the operation. This behavior can 
probably be linked to the fact that the patients have few 
and mild symptoms associated with G. Finally, we have 
found that in a long-term follow-up, there are no specific 
food intolerances related to G. 
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of the caloric intake could be inaccurate because of the 
following reasons: 
- a wrong recording or a mistaken assessment of the 
quantity and quality of food really consumed by the 
patient;
- a weekly nutritional record may not be representative of 
usual eating habits;
- furthermore, the patient’s caloric requirement may be 
inaccurate because the formula used for its valuation is 
only an estimation of resting energy expenditure (Harris-
Benedict formula).
The most frequent postprandial symptoms (Tab. III) were 
those of reduced gastric volume: abdominal swelling 
(62%) and early satiety (59%), while the rapid emptying 
symptoms (dumping syndrome, diarrhea/malabsorption) 
were practically absent. This fact can be explained by the 
digestive type of reconstruction employed (Roux-en-Y). A 
possible limit of this analysis could be linked to the period 
of follow-up considered in the study (over 4 months after 
surgery). In fact the symptoms related to a rapid emptying of 
the stomach usually refer to the early postoperative period, 
whereas only 5% of the patients suffered from their chronic 
presence (8). Of the 17 patients suffering from at least 1 
intolerance, a large variety of foods caused postprandial 
symptoms (Tab. IV), with 9 patients intolerant to more than 
1 food at the same time. There is no relationship between 
the length of time elapsed after surgery and the presence 
of intolerance. However, we did not consider the immediate 
postoperative period in our analysis, so we cannot 
estimate whether some patients had had only an early and 
transient intolerance to a specific food. Our study does not 
confirm the responsibility of pastry products (percentage 
of simple carbohydrates) or milk and dairy products in 
the development of intolerance or symptoms. From our 
data, we can suppose that food intolerance depends on 
individual characteristics of the various patients, such as 
dietary habits, clinical conditions, and social and familial 
environment. 
We usually suggest to patients undergoing G that they drink 
liquids 45 or 50 minutes before or after their meals; in fact, 
reduction of liquid intake is necessary to delay the sense 
of abdominal swelling, early satiety and epigastric pain, 
and to prevent diarrhea, nausea, and vomiting. Despite 
this advice, 28 out of 32 patients drank during their meals 
and only 5 referred symptoms. These last data confirm that 
symptoms tend to decrease during follow-up, and patients 
return to their preoperative drinking habits. 
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